$Tonix Pharmaceuticals (TNXP.US)$CHATHAM, N.J. - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a biopharmaceutical company, has announced its intention to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Tonmya™, a non-opioid analgesic aimed at treating fibromyalgia. The company plans to apply to the second half of 2024 following promising results from two Phase 3 trials.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
73103485 : hello are you still here?
Trytosaveabit OP 73103485 : What’s up?